Accuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System

被引:14
|
作者
Alva, Shridhara [1 ]
Brazg, Ronald [2 ]
Castorino, Kristin [3 ]
Kipnes, Mark [4 ]
Liljenquist, David R. [5 ]
Liu, Hanqing [1 ]
机构
[1] Abbott Diabet Care, Alameda, CA 94502 USA
[2] Rainier Clin Res Ctr, Renton, WA USA
[3] Sansum Diabet Res Inst, Santa Barbara, CA USA
[4] Diabet & Glandular Dis Clin, San Antonio, TX USA
[5] Rocky Mt Diabet Ctr, Idaho Falls, ID USA
关键词
FSL3 CGM system; FSL2 CGM system; Continuous glucose monitoring; Self-monitoring blood glucose; YSI reference;
D O I
10.1007/s13300-023-01385-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionWe have evaluated the performance of the FreeStyle Libre (R) 3 continuous glucose monitoring system (FSL3) compared to (1) the venous plasma reference for participants aged >= 6 years and (2) the fingerstick capillary blood glucose (BG) reference for pediatric participants aged 4 and 5 years. The analytical performance of the third-generation factory-calibrated FSL3 CGM system was compared to the plasma venous blood glucose reference using the YSI 2300 STAT PLUS Glucose and Lactate Analyzer (the YSI reference) and the self-monitoring blood glucose (SMBG) reference for participants aged >= 6 years and participants aged 4 and 5 years, respectively.MethodsA total of 108 participants aged >= 4 years with type 1 or type 2 diabetes from four sites in the USA were enrolled in the study. The data of 100 participants were ultimately evaluated. Adult participants (aged >= 18 years) participated in three in-clinic sessions, and pediatric participants (aged 4-17 years) participated in up to two in-clinic sessions, all stratified to provide data for days 1, 2, 3, 7, 8, 9, 12, 13 or 14 of sensor wear. Performance evaluation included accuracy measures, such as proportion of CGM values that fell within +/- 20% or +/- 20 mg/dL (1.1 mmol/L) of the reference glucose values, and difference measures, such as the mean absolute relative difference (MARD) between the CGM and reference values.ResultsData from the 100 study participants were analyzed. The overall MARD was 7.8%, and 93.4% of the CGM values were within +/- 20% or +/- 20 mg/dL of the YSI reference for participants aged >= 6 years, with 6845 CGM-YSI matched pairs. The performance was stable over the 14-day wear period. For participants aged 4-5 years, MARD was 10.0%, and 88.9% of the CGM values were within 20%/20 mg/dL compared to a SMBG reference. No serious adverse events were reported.ConclusionsThe FSL3 CGM system demonstrated accurate performance across the dynamic glycemic range during the 14-day sensor wear period.
引用
收藏
页码:767 / 776
页数:10
相关论文
共 50 条
  • [31] Hemodialysis Procedure-Associated Autonomic Imbalance and Cardiac Arrhythmias: Insights From Continuous 14-Day ECG Monitoring
    Rogovoy, Nichole M.
    Howell, Stacey J.
    Lee, Tiffany L.
    Hamilton, Christopher
    Perez-Alday, Erick A.
    Kabir, Muammar M.
    Zhang, Yanwei
    Kim, Esther D.
    Fitzpatrick, Jessica
    Monroy-Trujillo, Jose M.
    Estrella, Michelle M.
    Sozio, Stephen M.
    Jaar, Bernard G.
    Parekh, Rulan S.
    Tereshchenko, Larisa G.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (19):
  • [32] Clarke Error Grid and continuous Clarke Error Grid Analysis of the accuracy of the 5-day FreeStyle Navigator Continuous Glucose Monitoring System
    Weinstein, R. L.
    Schwartz, S. L.
    Brazg, R. L.
    Bugler, J. R.
    Peyser, T. A.
    McGarraugh, G. V.
    DIABETOLOGIA, 2006, 49 : 583 - 583
  • [33] Comparing 14-day adhesive patch with 24-h Holter monitoring
    Cheung, Christopher C.
    Kerr, Charles R.
    Krahn, Andrew D.
    FUTURE CARDIOLOGY, 2014, 10 (03) : 319 - 322
  • [34] Hypoglycemia Reduction and Accuracy of Continuous Glucose Monitoring
    Kovatchev, Boris P.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 (08) : 530 - 533
  • [35] Safety and accuracy of neonatal continuous glucose monitoring
    Ohishi, Akira
    Ueno, Daizo
    Fujita, Tomoka
    Segawa, Yuki
    Yamamoto, Takuya
    Fujisawa, Yasuko
    Iijima, Shigeo
    PEDIATRICS INTERNATIONAL, 2023, 65 (01)
  • [36] New features and performance of a next generation SEVEN day continuous glucose monitoring system with apparent short lag time
    Bailey, T.
    Zisser, H.
    Chang, A.
    DIABETOLOGIA, 2009, 52 : S365 - S365
  • [37] New Features and Performance of a Next Generation Seven Day Continuous Glucose Monitoring System with Apparent Short Lag Time
    Bailey, Timothy S.
    Zisser, Howard
    Chang, Anna
    DIABETES, 2009, 58 : A108 - A108
  • [38] Comparison of a Novel 14-day Adhesive Continuous ECG Monitoring Patch to Traditional 24-hour Holter Monitoring in Symptomatic Arrhythmia Patients
    Barrett, P.
    Komatireddy, R.
    Topol, E. J.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2013, 182 : S374 - S374
  • [39] Lag Times in a Seventh-Generation Continuous Glucose Monitoring System
    Zhang, Xiaohe
    Reid, Jennifer L.
    Walker, Tomas C.
    Welsh, John
    Balo, Andrew
    DIABETES, 2022, 71
  • [40] Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study
    Garg, Satish K.
    Liljenquist, David
    Bode, Bruce
    Christiansen, Mark P.
    Bailey, Timothy S.
    Brazg, Ronald L.
    Denham, Douglas S.
    Chang, Anna R.
    Akturk, Halis
    Dehennis, Andrew
    Tweden, Katherine S.
    Kaufman, Francine R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 (02) : 84 - 92